
Next-generation Sequencing Market Analysis And Forecast To 2033: By Workflow (Pre-sequencing, Sequencing, NGS Data Analysis), By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing), By Application (Oncology, Cl
Description
Next-generation Sequencing Market Analysis And Forecast To 2033: By Workflow (Pre-sequencing, Sequencing, NGS Data Analysis), By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing), By Application (Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Others), By End-user (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Others), and By Region
Next-generation sequencing (NGS) is a type of DNA sequencing technology that is used to determine the precise order of nucleotides in a genome. NGS is also used to identify mutations, SNPs, and other variations in a genome. NGS technology has revolutionized the field of genomics by providing a more rapid and cost-effective method for sequencing genomes. NGS can sequence an entire human genome in a matter of days, whereas it would take months or years to sequence a genome using traditional methods.
Market Trends and Drivers
Growing technological developments in NGS instruments and technologies are further likely to offer significant market growth over the coming years. For instance, in January 2020, the Intelligence Advanced Research Projects Activity in the U.S. awarded a grant of USD 23 million to Harvard University, DNA Script, and Broad Institute. The institutes are conducting collaborative research to develop a novel technology that will combine enzymatic DNA synthesis and NGS into a single instrument. To better understand the link between genetics and disease, several countries have invested in their own national population genome mapping projects. Furthermore, millions of genomes are being sequenced by government groups to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. Efforts are being undertaken by the EU to improve the region's large-scale genomic data with projects such as France’s French Plan for Genomic Medicine 2025 and the U.K. 100,000 Genomes Project. Such initiatives have resulted in the growth of NGS informatics services in the region.
Market Restraints and Challenges
The high cost of sequencing is a major barrier to the adoption of NGS. The technology is still relatively new and the costs have not yet come down to a level that is affordable for many laboratories. In addition, the lack of standardization in NGS protocols means that there is no agreed upon set of best practices for data collection and analysis. This lack of standardization makes it difficult to compare results from different laboratories and makes it difficult to reproduce results. The need for skilled personnel is another challenge facing the NGS market. The technology is complex and requires a high level of technical expertise to operate. In addition, the data generated by NGS experiments can be very large and complex, making it difficult to analyze and interpret without the help of bioinformatics experts.
Global Next-generation Sequencing Market Segmental Overview
The report analyses the global Next-generation Sequencing Market based on workflow, technology, application, end-user, and region. Based on the workflow, the Next-generation Sequencing market is divided into Pre-sequencing, Sequencing, and NGS Data Analysis. By technology, the industry is bifurcated into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing. Based on application, the industry is categorized into oncology, clinical investigation, reproductive health, hla typing/immune system monitoring, metagenomics, epidemiology & drug development, and others. Based on end-user, the Next-generation Sequencing market is divided into academic research, clinical research, hospitals & clinics, pharma & biotech entities, and others. Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World.
COVID-19 Impact:
Following the World Health Organization's (WHO) declaration of COVID-19 as a pandemic, a diverse group of recognized pharmaceutical and biotechnology companies, have decided to step forward to boost the global research efforts to develop test kits and vaccines. Furthermore, major companies across the globe have increased their research and development capacities. This substantial focus on COVID-19 vaccine development offered a lucrative opportunity for the adoption of NGS during the pandemic period. For instance, a group of researchers in China utilized MinION Mk1C, a product by Oxford Nanopore Technologies (U.K.) for the sequencing of COVID-19 samples. In addition, factors such as extensive adoption of NGS technologies in clinical diagnostics due to rapid result time and faster processing are also projected to offer a favorable environment for market growth during the forecast period. For instance, in August 2020, Pediatrix Medical Group, GeneDx Inc., and OPKO Health signed an agreement to provide state-of-the-art, next-generation gene-sequencing to enhance clinical diagnosis in uncommon disorders for newborn intensive care units.
Major Players in the Global Next-generation Sequencing Market
Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Next-generation Sequencing market include Agilent Technologies, Inc, BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Oxford Nanopore Technologies, Cepheid, PerkinElmer, Inc., Eurofins Scientific, Qiagen N.V., and Thermo Fisher Scientific Inc. among others.
Recent Developments:
- In March 2021, Integrated DNA Technologies (IDT) announced the acquisition of Swift Biosciences, a pioneer in the development of NGS library preparation genomics kits for clinical, translational, and academic research
- In January 2021, Cerba Research announced the launch of its new tools to enhance R&D for vaccine development against infectious diseases, including COVID-19.
- In August 2020, Pediatrix Medical Group, GeneDx Inc., and OPKO Health signed an agreement to provide state-of-the-art, next-generation gene-sequencing to enhance clinical diagnosis in uncommon disorders for newborn intensive care unit.
Next Generation Sequencing Market Report Coverage:
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Next Generation Sequencing Market outlook and estimations from 2023 to 2033, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of the Next Generation Sequencing Market in terms of revenue ($Million) and Volume (Units).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Next Generation Sequencing industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country, market analysis is also presented in this report.
- The Next Generation Sequencing Market Study comprises an analysis of 23 countries. The research also encompasses a segment analysis of every country in terms of value (USD Million) throughout the study period.
- Analytical depiction of the Next Generation Sequencing Market along with current trends and future estimations to depict imminent investment pockets. The overall Next Generation Sequencing industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Next Generation Sequencing Market are also analyzed.
- The report also involves market strategy factors such as the ANSOFF Matrix, 4Ps Model, Demand-Supply Analysis, Competition Product Analysis, Recent Developments, Consumer Buying Interest, and Supply Chain Analysis among others.
Please Note:This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
359 Pages
- Chapter 1. Next-generation Sequencing Market Overview
- 1.1. Objectives of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Limitations
- 1.4. Research Methodologies
- 1.4.1. Secondary Research
- 1.4.2. Market Size Estimation Technique
- 1.4.3. Forecasting
- 1.4.4. Primary Research and Data Validation
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of the Market
- Chapter 3. Premium Insights on the Market
- 3.1. Market Attractiveness Analysis, By Region
- 3.2. Market Attractiveness Analysis, By Workflow
- 3.3. Market Attractiveness Analysis, By Technology
- 3.4. Market Attractiveness Analysis, By Application
- 3.5. Market Attractiveness Analysis, By End-user
- Chapter 4. Next-generation Sequencing Market Outlook
- 4.1. Next-generation Sequencing Market Segmentation
- 4.2. Market Dynamics
- 4.2.1. Market Drivers
- 4.2.1.1. Driver 1
- 4.2.1.2. Driver 2
- 4.2.1.3. Driver 3
- 4.2.2. Market Restraints
- 4.2.2.1. Restraint 1
- 4.2.2.2. Restraint 2
- 4.2.3. Market Opportunities
- 4.2.3.1. Opportunity 1
- 4.2.3.2. Opportunity 2
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Threat of New Entrants
- 4.3.2. Threat of Substitutes
- 4.3.3. Bargaining Power of Buyers
- 4.3.4. Bargaining Power of Supplier
- 4.3.5. Competitive Rivalry
- 4.4. PESTLE Analysis
- 4.5. Value Chain Analysis
- 4.5.1. Raw Industry Vertical Suppliers
- 4.5.2. Manufacturers
- 4.5.3. Wholesalers and/or Retailers
- 4.6. Impact of COVID-19 on the Next-generation Sequencing Market
- 4.7. Impact of the Russia and Ukraine War on the Next-generation Sequencing Market
- Chapter 5. Next-generation Sequencing Market By Workflow
- 5.1. Market Overview
- 5.2. Pre-sequencing
- 5.2.1. Market Size And Forecast, 2022-2032 ($Million)
- 5.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 5.3. Sequencing
- 5.3.1. Market Size And Forecast, 2022-2032 ($Million)
- 5.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 5.4. NGS Data Analysis
- 5.4.1. Market Size And Forecast, 2022-2032 ($Million)
- 5.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- Chapter 6. Next-generation Sequencing Market By Application
- 6.1. Market Overview
- 6.2. WGS
- 6.2.1. Market Size And Forecast, 2022-2032 ($Million)
- 6.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 6.3. Whole Exome Sequencing
- 6.3.1. Market Size And Forecast, 2022-2032 ($Million)
- 6.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 6.4. Targeted Sequencing & Resequencing
- 6.4.1. Market Size And Forecast, 2022-2032 ($Million)
- 6.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- Chapter 7. Next-generation Sequencing Market By Technology
- 7.1. Market Overview
- 7.2. Oncology
- 7.2.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 7.3. Clinical Investigation
- 7.3.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 7.4. Reproductive Health
- 7.4.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 7.5. HLA Typing/Immune System Monitoring
- 7.5.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.5.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 7.6. Metagenomics, Epidemiology & Drug Development
- 7.6.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.6.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 7.7. Others
- 7.7.1. Market Size And Forecast, 2022-2032 ($Million)
- 7.7.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- Chapter 8. Next-generation Sequencing Market By End-user
- 8.1. Market Overview
- 8.2. Academic Research
- 8.2.1. Market Size And Forecast, 2022-2032 ($Million)
- 8.2.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 8.3. Clinical Research
- 8.3.1. Market Size And Forecast, 2022-2032 ($Million)
- 8.3.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 8.4. Hospitals & Clinics
- 8.4.1. Market Size And Forecast, 2022-2032 ($Million)
- 8.4.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 8.5. Pharma & Biotech Entities
- 8.5.1. Market Size And Forecast, 2022-2032 ($Million)
- 8.5.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- 8.6. Others
- 8.6.1. Market Size And Forecast, 2022-2032 ($Million)
- 8.6.2. Market Size And Forecast, By Region, 2022-2032 ($Million)
- Chapter 9. Multi-Cloud Management Market, By Region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key Market Trends And Opportunities
- 9.2.2. North America Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.2.3. North America Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.2.4. North America Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.2.5. North America Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.2.6. North America Next-generation Sequencing Market Size And Forecast by Country, ($Million)
- 9.2.7. The U.S.
- 9.2.7.1. The U.S. Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.2.7.2. The U.S. Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.2.7.3. The U.S. Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.2.7.4. U.S. Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.2.8. Canada
- 9.2.8.1. Canada Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.2.8.2. Canada Next-generation Sequencing Market Size And Forecast by Application Concentrators, ($Million)
- 9.2.8.3. Canada Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.2.8.4. Canada Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.2.9. Mexico
- 9.2.9.1. Mexico Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.2.9.2. Mexico Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.2.9.3. Mexico Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.2.9.4. Mexico Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3. Europe
- 9.3.1. Key Market Trends And Opportunities
- 9.3.2. Europe Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.3. Europe Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.4. Europe Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.5. Europe Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3.6. Europe Next-generation Sequencing Market Size And Forecast by Country, ($Million)
- 9.3.6.1. Germany
- 9.3.6.2. Germany Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.6.3. Germany Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.6.4. Germany Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.6.5. Germany Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3.7. France
- 9.3.7.1. France Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.7.2. France Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.7.3. France Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.7.4. France Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.8. U.K
- 9.3.8.1. U.K. Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.8.2. U.K. Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.8.3. U.K. Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.8.4. U.K. Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.9. Spain
- 9.3.9.1. Spain Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.9.2. Spain Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.9.3. Spain Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.9.4. Spain Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3.10. Italy
- 9.3.10.1. Italy Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.10.2. Italy Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.10.3. Italy Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.10.4. Italy Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3.11. Russia
- 9.3.11.1. Russia Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.11.2. Russia Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.11.3. Russia Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.11.4. Russia Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.3.12. Rest of Europe
- 9.3.12.1. Rest of Europe Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.3.12.2. Rest of Europe Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.3.12.3. Rest of Europe Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.3.12.4. Rest of Europe Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4. Asia-Pacific
- 9.4.1. Key Market Trends And Opportunities
- 9.4.2. Asia-Pacific Next-generation Sequencing Market Size And Forecast by Country, ($Million)
- 9.4.3. Asia-Pacific Next-generation Sequencing Market Size And Forecast By Workflow, ($Million)
- 9.4.4. Asia-Pacific Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.5. Asia-Pacific Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.6. Asia-Pacific Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4.7. China
- 9.4.7.1. China Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.4.7.2. China Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.7.3. China Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.7.4. China Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4.8. India
- 9.4.8.1. India Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.4.8.2. India Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.8.3. India Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.8.4. India Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4.9. Japan
- 9.4.9.1. Japan Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.4.9.2. Japan Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.9.3. Japan Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.9.4. Japan Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4.10. South Korea
- 9.4.10.1. South Korea Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.4.10.2. South Korea Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.10.3. South Korea Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.10.4. South Korea Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.4.11. Rest of APAC
- 9.4.11.1. Rest of APAC Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.4.11.2. Rest of APAC Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.4.11.3. Rest of APAC Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.4.11.4. Rest of APAC Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.5. Rest of The World
- 9.5.1. Key Market Trends And Opportunities
- 9.5.2. Rest of The World Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.5.3. Rest of The World Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.5.4. Rest of The World Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.5.5. Rest of The World Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.5.6. Rest of The World Next-generation Sequencing Market Size And Forecast by Country, ($Million)
- 9.5.7. Latin America
- 9.5.7.1. Latin America Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.5.7.2. Latin America Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.5.7.3. Latin America Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.5.7.4. Latin America Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.5.8. Middle East
- 9.5.8.1. Middle East Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.5.8.2. Middle East Next-generation Sequencing Market Size And Forecast by Application, ($Million)
- 9.5.8.3. Middle East Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.5.8.4. Middle East Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- 9.5.9. Africa
- 9.5.9.1. Africa Next-generation Sequencing Market Size And Forecast By Workflow , ($Million)
- 9.5.9.2. Africa Next-generation Sequencing Market Size And Forecast By Application, ($Million)
- 9.5.9.3. Africa Next-generation Sequencing Market Size And Forecast By Technology, ($Million)
- 9.5.9.4. Africa Next-generation Sequencing Market Size And Forecast By End-user, ($Million)
- Chapter 10. Competitive Landscape
- 10.1. Market Overview
- 10.2. Market Share Analysis/Key Player Positioning
- 10.3. Developmental Strategy Benchmarking
- 10.3.1. New Testing Type Development
- 10.3.2. Chemical-based Launches
- 10.3.3. Business Expansions
- 10.3.4. Partnerships, Joint Ventures, And Collaborations
- 10.3.5. Mergers And Acquisitions
- Chapter 11. Company Profiles
- 11.1. Agilent Technologies, Inc
- 11.1.1. Company Snapshot
- 11.1.2. Financial Performance
- 11.1.3. Chemical-based offerings
- 11.1.4. Key Strategic Initiatives
- 11.1.5. SWOT Analysis
- 11.2. BGI Group
- 11.2.1. Company Snapshot
- 11.2.2. Financial Performance
- 11.2.3. Chemical-based offerings
- 11.2.4. Key Strategic Initiatives
- 11.2.5. SWOT Analysis
- 11.3. F. Hoffmann-La Roche AG
- 11.3.1. Company Snapshot
- 11.3.2. Financial Performance
- 11.3.3. Chemical-based offerings
- 11.3.4. Key Strategic Initiatives
- 11.3.5. SWOT Analysis
- 11.4. Illumina Inc
- 11.4.1. Company Snapshot
- 11.4.2. Financial Performance
- 11.4.3. Chemical-based offerings
- 11.4.4. Key Strategic Initiatives
- 11.4.5. SWOT Analysis
- 11.5. Oxford Nanopore Technologies
- 11.5.1. Company Snapshot
- 11.5.2. Financial Performance
- 11.5.3. Chemical-based offerings
- 11.5.4. Key Strategic Initiatives
- 11.5.5. SWOT Analysis
- 11.6. Cepheid
- 11.6.1. Company Snapshot
- 11.6.2. Financial Performance
- 11.6.3. Chemical-based offerings
- 11.6.4. Key Strategic Initiatives
- 11.6.5. SWOT Analysis
- 11.7. PerkinElmer, Inc.
- 11.7.1. Company Snapshot
- 11.7.2. Financial Performance
- 11.7.3. Chemical-based offerings
- 11.7.4. Key Strategic Initiatives
- 11.7.5. SWOT Analysis
- 11.8. Eurofins Scientific
- 11.8.1. Company Snapshot
- 11.8.2. Financial Performance
- 11.8.3. Chemical-based offerings
- 11.8.4. Key Strategic Initiatives
- 11.8.5. SWOT Analysis
- 11.9. Qiagen N.V.
- 11.9.1. Company Snapshot
- 11.9.2. Financial Performance
- 11.9.3. Chemical-based offerings
- 11.9.4. Key Strategic Initiatives
- 11.9.5. SWOT Analysis
- 11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Snapshot
- 11.10.2. Financial Performance
- 11.10.3. Chemical-based offerings
- 11.10.4. Key Strategic Initiatives
- 11.10.5. SWOT Analysis
- *The List of Company Is Subject To Change During The Final Compilation of The Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.